prt2527
·Code: PRT2527
prt2527: 1 clinical trial tracked.
prt2527 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about prt2527, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With Relapsed/Refractory Hematologic Malignancies
Primary endpoint: Dose limiting toxicity (DLT) of PRT2527
Interventionalopen86 enrolledStarted 2023-09Completion 2026-0124 sites · Australia, Canada, France, Germany…Prelude Therapeutics